RecruitingNCT06160310
Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry)
Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry
Sponsor
David M. Ritter
Enrollment
300 participants
Start Date
Jul 1, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
This study is an observational registry designed to gather information about Tuberous Sclerosis Complex (TSC) and Lymphangioleiomyomatosis (LAM) in pregnant women and their child.
Eligibility
Sex: FEMALE
Inclusion Criteria7
- A pregnant woman with a clinical or genetic diagnosis of TSC as determined by the 2021 Consensus Guidelines (1)
- A pregnant woman with a diagnosis of LAM
- A pregnant woman with a variant of uncertain significance in TSC 1 or TSC 2
- A pregnant woman who is pregnant and the fetus has a 50% chance of TSC as deemed by the PI or Sub-Is
- A pregnant woman whose fetus is found to have concern for TSC secondary to rhabdomyomas, tubers, or congenital subependymal giant cell astrocytoma.
- An infant born to an enrolled individual.
- Infants diagnosed with TSC whose birth mother was not enrolled.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06160310
Related Trials
Study of the Disease Process of Lymphangioleiomyomatosis
NCT000014651 location
Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY
NCT0548583118 locations
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
NCT0510498311 locations
TSC Biosample Repository and Natural History Database
NCT0567609924 locations
Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II
NCT0639200920 locations